7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Effects of betamethasone on inflammation and emphysema induced by cadmium nebulisation in rats.

      European Journal of Pharmacology
      Animals, Anti-Inflammatory Agents, adverse effects, pharmacology, Betamethasone, Bronchoalveolar Lavage Fluid, Cadmium, administration & dosage, toxicity, Cell Count, Male, Matrix Metalloproteinases, metabolism, Microscopy, Nebulizers and Vaporizers, Pneumonia, chemically induced, pathology, Pulmonary Emphysema, Rats, Rats, Sprague-Dawley, Tissue Inhibitor of Metalloproteinases

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cadmium (Cd) induces centrilobular emphysema and is suspected to contribute to tobacco related lung diseases as chronic obstructive pulmonary disease (COPD). This study aimed to check whether the inflammatory process observed in rats exposed to nebulised Cd is resistant to betamethasone as observed in COPD and to determine the influence of this drug on airspace enlargement together with the MMP-2-9/TIMP-1-2 imbalance. Our results showed that betamethasone induced emphysema by itself in healthy rats. Moreover, pre-treatment of rats with betamethasone could only partially modulate the increase in bronchoalveolar lavage fluid cell counts and the absence of preventive effect of this compound against emphysema development is associated with its inability to rebalance the MMP-2-9/TIMP-1-2 ratio.

          Related collections

          Author and article information

          Comments

          Comment on this article